Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased due to growth in occupational physician and public health nurse services, expansion of existing GLTD contracts, the accumulation of recurring revenue from “ADVANTAGE HARMONY,” and the contribution from Kenko Nenrei Small Amount and Short-Term Insurance Co., Ltd., which became a subsidiary in the previous fiscal year. Operating profit declined due to increases in personnel expenses, marketing expenses and temporary expenses. Interim net income attributable to owners of the parent increased due to the recognition of gains on the sale of investment securities.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | 4,801 Millions of yen (YoY +5.3%) |
| Operating profit | 233 Millions of yen (YoY -16.6%) |
| Ordinary income | 245 Millions of yen (YoY -13.5%) |
| Profit attributable to owners of the parent | 209 Millions of yen (YoY +12.0%) |
| Net income per share | ¥13.31 |
| Equity ratio | End of the current fiscal period 47 / End of previous period 50.4 |
| Total assets | 9,280 Millions of yen |
| Net assets | 4,413 Millions of yen |
| Cash flows from operating activities | 1,449 Millions of yen |
| Cash flows from investing activities | -372 Millions of yen |
| Cash flows from financing activities | -384 Millions of yen |
| Cash and cash equivalents at end of period | 2,531 Millions of yen |
| Full-year earnings forecast | Net Sales 10,700 Millions of yen (YoY +7.8%) / Operating profit 1,240 Millions of yen (YoY +24.3%) / Ordinary income 1,240 Millions of yen (YoY +23.5%) / Net income 844 Millions of yen (YoY +22.9%) |
| Revision to Earnings Forecast | No |
| Annual Dividend Forecast | 17 Yen → 19 Yen |
| Segment revenue | Mentality and Healthcare Management Business 3,642 Millions of yen (YoY +2.8%), Workplace Insurance and Work-Life Balance Support Business 1,032 Millions of yen (YoY +9.5%), Small-Amount and Short-Term Insurance Business 126 Millions of yen (YoY +76.2%) |
| Segment profit | Mentality and Healthcare Management Business 490 Millions of yen (YoY +9.9%), Workplace Insurance and Work-Life Balance Support Business 249 Millions of yen (YoY +4.6%), Small-Amount and Short-Term Insurance Business -25 Millions of yen |
| Depreciation and amortization | 451 Millions of yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on Sale of Investment Securities ¥64,460 thousand / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Not disclosed / Excluded Not disclosed / Company name Not disclosed / Notes Material changes in the scope of consolidation during the interim period: None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 16,280,200 |
| Treasury Shares at Period-End | 558,974 |
| Factors Behind Changes in Business Performance | Revenue increased due to growth in occupational physician and public health nurse services, expansion of existing GLTD contracts, the accumulation of recurring revenue from “ADVANTAGE HARMONY,” and the contribution from Kenko Nenrei Small Amount and Short-Term Insurance Co., Ltd., which became a subsidiary in the previous fiscal year. Operating profit declined due to increases in personnel expenses, marketing expenses and temporary expenses. Interim net income attributable to owners of the parent increased due to the recognition of gains on the sale of investment securities. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to growth in occupational physician and public health nurse services, expansion of existing GLTD contracts, the accumulation of recurring revenue from “ADVANTAGE HARMONY,” and the contribution from Kenko Nenrei Small Amount and Short-Term Insurance Co., Ltd., which became a subsidiary in the previous fiscal year. Operating profit declined as higher personnel expenses associated with wage increases, marketing expenses for acquiring new customers, and other temporary expenses outweighed the decrease in software amortization. Interim net income attributable to owners of the parent increased due to the recognition of gains on the sale of investment securities.